Triflunordazepam
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
5-phenyl-7-(trifluoromethyl)-1,3-dihydro-1,4-benzodiazepin-2-one | |
| Identifiers | |
| CAS Number |
2285-16-7 |
| ATC code | None |
| PubChem | CID 16795 |
| Chemical data | |
| Formula | C16H11F3N2O |
| Molar mass | 304.267 g/mol |
| |
| (verify) | |
Triflunordazepam (also known as Ro5-2904)[1] is a drug which is a benzodiazepine derivative with high GABAA receptor affinity, and has anticonvulsant effects.[2][3]
See also
References
- ↑ DE Patent 1136709
- ↑ Archives Internationales de Pharmacodynamie et de Thérapie. (1965). Vol 154, p 131.
- ↑ So SS, Karplus M (December 1996). "Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors". Journal of Medicinal Chemistry 39 (26): 5246–56. doi:10.1021/jm960536o. PMID 8978853.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, February 27, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
